An Economic Model to Compare Linezolid and Vancomycin for the Treatment of Confirmed Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.187
https://www.valueinhealthjournal.com/article/S1098-3015(13)02092-5/fulltext
Title :
An Economic Model to Compare Linezolid and Vancomycin for the Treatment of Confirmed Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02092-5&doi=10.1016/j.jval.2013.08.187
First page :
A354
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
172